We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

113 hedge funds and large institutions have $377M invested in Voyager Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 40 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,983% more call options, than puts

Call options by funds: $1.45M | Put options by funds: $12K

36% more capital invested

Capital invested by funds: $277M → $377M (+$99.7M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.28% less ownership

Funds ownership: 81.5% → 80.23% (-1.3%)

7% less funds holding

Funds holding: 121 → 113 (-8)

13% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 40

40% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 20

Holders
113
Holders Change
-8
Holders Change %
-6.61%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
35
Reduced
40
Closed
20
Calls
$1.45M
Puts
$12K
Net Calls
+$1.44M
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$4.75M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$2.61M
3
BlackRock
BlackRock
New York
+$2.58M
4
Axa
Axa
France
+$2.11M
5
ClearBridge Investments
ClearBridge Investments
New York
+$1.97M

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$4.01M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$2.53M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.29M
4
Millennium Management
Millennium Management
New York
-$2.03M
5
AC
Armistice Capital
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$2.24M -$613K -52,706 -23%
Charles Schwab
27
Charles Schwab
California
$2.1M -$459K -39,424 -19%
FT
28
Fiduciary Trust
Massachusetts
$1.96M – – –
Man Group
29
Man Group
United Kingdom
$1.58M -$139K -11,978 -9%
Ameriprise
30
Ameriprise
Minnesota
$1.56M +$327K +28,101 +29%
Los Angeles Capital Management
31
Los Angeles Capital Management
California
$1.52M +$391K +33,598 +39%
Massachusetts Financial Services
32
Massachusetts Financial Services
Massachusetts
$1.49M +$1.37M +118,169 New
Marshall Wace
33
Marshall Wace
United Kingdom
$1.21M -$1.15M -98,490 -51%
NIM
34
Needham Investment Management
New York
$1.14M – – –
HAM
35
HHR Asset Management
New Jersey
$1.12M -$171K -14,670 -14%
QI
36
QS Investors
New York
$900K – – –
Russell Investments Group
37
Russell Investments Group
United Kingdom
$837K -$79.2K -6,807 -9%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$798K -$100K -8,600 -12%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$797K +$561K +48,225 +324%
HW
40
Hancock Whitney
Mississippi
$778K -$155K -13,329 -18%
Invesco
41
Invesco
Georgia
$756K -$282K -24,216 -29%
CS
42
Credit Suisse
Switzerland
$756K +$384K +33,029 +123%
BNP Paribas Asset Management
43
BNP Paribas Asset Management
France
$755K +$9.24K +794 +1%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$723K +$45.7K +3,926 +7%
Swiss National Bank
45
Swiss National Bank
Switzerland
$679K +$9.3K +800 +2%
Deutsche Bank
46
Deutsche Bank
Germany
$654K +$493K +42,414 +450%
AQR Capital Management
47
AQR Capital Management
Connecticut
$651K -$81K -6,966 -12%
AA
48
ALPS Advisors
Colorado
$640K -$194K -16,701 -25%
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$583K +$29.3K +2,520 +6%
Morgan Stanley
50
Morgan Stanley
New York
$557K +$124K +10,640 +32%
1
2
3 4 5

VYGR Hedge Fund Activity: Q2 2020 in Review

113 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2020, worth a combined $377M — up 36% from $277M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VYGR and 12 opened new positions — a net loss of 8 holders — while 40 trimmed existing stakes and 35 added.

The largest buyer was Citadel Advisors, adding an estimated $4.75M. The largest seller was Casdin Capital, cutting an estimated $4.01M.

  • 113 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2020, down from 121 in Q1 2020.
  • Funds reported $377M of Voyager Therapeutics stock for Q2 2020, up 36% quarter-over-quarter.
  • 12 funds opened new Voyager Therapeutics positions in Q2 2020 and 20 closed out, a net change of -8 holders.
  • The largest Voyager Therapeutics buyer in Q2 2020 was Citadel Advisors, an estimated $4.75M added.
  • The largest Voyager Therapeutics seller in Q2 2020 was Casdin Capital, an estimated $4.01M sold.

Based on aggregated 13F filings for Q2 2020.